Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Accumulated Expenses: 2018-2019

  • Arcturus Therapeutics Holdings' Other Accumulated Expenses was N/A to $560,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $560,000, marking a year-over-year change of. This contributed to the annual value of $674,000 for FY2018, which is N/A change from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Other Accumulated Expenses stood at $560,000 for Q3 2019, which was down 55.34% from $1.3 million recorded in Q2 2019.
  • Arcturus Therapeutics Holdings' 5-year Other Accumulated Expenses high stood at $1.3 million for Q2 2019, and its period low was $560,000 during Q3 2019.
  • Its 2-year average for Other Accumulated Expenses is $829,333, with a median of $674,000 in 2018.